Advancements in targeted therapy for gastric cancer
Therapeutic Advances in Gastroenterology
Published online on April 16, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Gastric cancer (GC) ranks among the most prevalent malignancies of the gastrointestinal system. For patients with advanced-stage disease undergoing surgical resection, postoperative 5-year survival rates remain critically low, typically below 20%. ...
Gastric cancer (GC) ranks among the most prevalent malignancies of the gastrointestinal system. For patients with advanced-stage disease undergoing surgical resection, postoperative 5-year survival rates remain critically low, typically below 20%. ...